Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NTGN

Neon Therapeutics (NTGN) Stock Price, News & Analysis

Neon Therapeutics logo

About Neon Therapeutics Stock (NASDAQ:NTGN)

Advanced Chart

Key Stats

Today's Range
$3.07
$3.07
50-Day Range
$2.77
$3.07
52-Week Range
$0.88
$6.25
Volume
N/A
Average Volume
516,108 shs
Market Capitalization
$88.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NTGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

NTGN Stock News Headlines

BCYC Bicycle Therapeutics plc
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
NTGN_old Historical Data
NBCO Neon Bloom, Inc.
See More Headlines

NTGN Stock Analysis - Frequently Asked Questions

Neon Therapeutics Inc (NASDAQ:NTGN) posted its quarterly earnings data on Monday, March, 2nd. The company reported ($0.63) EPS for the quarter, topping analysts' consensus estimates of ($0.66) by $0.03.

Neon Therapeutics (NTGN) raised $101 million in an initial public offering on Wednesday, June 27th 2018. The company issued 6,300,000 shares at $15.00-$17.00 per share. Morgan Stanley, BofA Merrill Lynch and Mizuho Securities acted as the underwriters for the IPO and Oppenheimer was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neon Therapeutics investors own include VBI Vaccines (VBIV), Vaxart (VXRT), Anavex Life Sciences (AVXL), Occidental Petroleum (OXY), Sorrento Therapeutics (SRNE), Aduro Biotech (ADRO) and Altimmune (ALT).

Company Calendar

Last Earnings
3/02/2020
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:NTGN
CIK
N/A
Fax
N/A
Employees
102
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$79.78 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-199.09%
Return on Assets
-137.14%

Debt

Debt-to-Equity Ratio
0.43
Current Ratio
1.58
Quick Ratio
3.00

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.50 per share
Price / Book
6.14

Miscellaneous

Outstanding Shares
28,967,000
Free Float
N/A
Market Cap
$88.93 million
Optionable
Not Optionable
Beta
-0.81
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:NTGN) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners